A Study of Danoprevir in Combination With Low-Dose Ritonavir in Healthy Subjects

NCT01398293 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: danoprevir
DRUG: danoprevir
DRUG: danoprevir placebo
DRUG: moxifloxacin
DRUG: moxifloxacin placebo
DRUG: ritonavir
DRUG: ritonavir placebo

Sponsor

Hoffmann-La Roche